The Arora Report

Rss Facebook Twitter Linkedin

Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

NEW PROFIT TAKING ZONE FOR SNOWFLAKE STOCK $SNOW

September 16, 2020

This post was just published on ZYX Buy Change Alert. The new opening indication on SNOW is $225 to $235. What To Do Now Those in the stock may consider taking 10% tranche at the open and profits on another 10% tranche in the zone of $230 to $245. This supersedes the prior post. Those not in the stock may wait for a signal on the Real Time Feed. Please also read the prior post. A knowledgeable investor would have turned $100,000 into over $1,000,000 with the help from The Arora Report. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR

Read More »

SNOWFLAKE STOCK IPO: TAKE PARTIAL PROFITS AT THE OPEN, OPENING INDICATION $SNOW

September 16, 2020

This post was just published on ZYX Buy Change Alert. The opening indication of Snowflake (SNOW) keeps on rising after the IPO was priced at $120.  Please start out by reading the section on Snowflake in the Morning Capsule and the prior post on Snowflake. The latest indication as of this writing for the open is $190 to $195. What To Do Now Those in the stock may consider taking profits on a 10% tranche at the open and on another 10% tranche take profits in the zone of $205 to $215.  Consider continuing to hold the remaining position. Those not in

Read More »

DIGGING BELOW THE SURFACE SHOWS WEAKNESS IN THE STOCK MARKET $NVDA $SFTBY $DJIA $SPX $NDX $QQQ $GLD $SLV $USO $SPY

September 15, 2020

This post was published yesterday in The Arora Report  paid services. To gain an edge, this is what you need to know now. Under The Surface  On the surface stocks, especially momo stocks, are being aggressively bought.  However, under the surface, there is weakness relative to the aggressive buying that occurred in August. Let’s explore it with the help of a chart. Please click here for an annotated chart of NVIDIA (NVDA). Note the following: NVDA is one of the largest semiconductor stocks in the world. NVDA is one of the favored momo stocks. NVDA has announced that it is buying ARM from SFTBY of Japan.  Long time

Read More »

A NEW IDEA ON SUMO LOGIC IPO $SUMO

September 15, 2020

This post was just published on ZYX Buy Change Alert. Sumo Logic  (SUMO) is a new IPO that is likely to start trading this week.  The company is a provider of cloud based real time analytics software.  This is a call to get up to 70% of the full core position size in the IPO.  Many of our subscribers who are ultra wealthy and money managers are able to get this IPO.  However if you are trading with a discount broker or do not have already established connections, you are not likely to get this IPO. Consider stops in the zone of

Read More »

BIOTECH GILEAD MAY BECOME THE FUTURE LEADER IN SOLID TUMOR CANCER TREATMENT — A STOCK MARKET OPPORTUNITY $GILD $IMMU

September 14, 2020

This is the golden age of biotech.  Huge profits are to be made by astute investors from biotech breakthroughs.  One great opportunity for long term investors is Gilead (GILD). Gilead is one of the cheapest large cap biotechs around.  Gilead just bought  Immunomedics (IMMU).  In our analysis, Gilead has the potential to become the future leader in solid tumor cancer treatment. When And How To Buy? Investors should not rush and buy Gilead.  They should pay attention to Buy Now ratings, buy zone, target zone and most importantly the position size that is appropriate at this time.  These details will

Read More »

WEEKLY STOCK MARKET DIGEST: A TECHNICAL INFLECTION POINT IN THE STOCK MARKET, INFLATION RUNS HOTTER $DJIA $SPX $QQQ $GLD $SLV $USO

September 13, 2020

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section What To Do Now. A TECHNICAL INFLECTION POINT IN THE STOCK MARKET, INFLATION RUNS HOTTER September 11, 2020 To gain an edge, this is what you need to know today.

Read More »

NVIDIA BUYOUT OF ARM WILL CREATE MANY TRADING OPPORTUNITIES INCLUDING THOSE IN AMD AND INTEL $NVDA $AMD $INTC $SFTBY

September 13, 2020

This post was just published on ZYX Buy Change Alert. There is a report that SoftBank (SFTBY) is close to selling ARM Holdings to NVIDIA (NVDA).  Long time subscribers to The Arora Report may recall making a lot of money from Arora signals on ARM Holdings when it was a public company.  A potential buyout will create many trading opportunities in other semiconductor stocks such as AMD (AMD) and Intel (INTC) from both long and short sides. Please stay tuned. The Chart Please click here for the chart is of semiconductor ETF SMH. Note the following: The trendline that has been in

Read More »

SELECT MOMO STOCKS SLAMMED, $3 TRILLION DEFICIT $DJIA $SPX $NDX $QQQ $GLD $SLV $USO $SPY

September 12, 2020

This post was published yesterday in The Arora Report  paid services. To gain an edge, this is what you need to know now. Select Momo Stocks Slammed Normally we do not discuss individual stocks in the Afternoon Capsule or the Morning Capsule. However we do illustrate with individual stocks when there is a major development with broader impact. What has happened in the stock market today by the slamming of select momo stocks may have broader impact. Let’s explore with the chart of Peloton (PTON). Please click here for an annotated chart of Peloton. Note the following: PTON stock ran into

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content